.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Dow
Harvard Business School
Fish and Richardson
Healthtrust
Mallinckrodt
Federal Trade Commission
Argus Health
QuintilesIMS
Teva

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021620

« Back to Dashboard
NDA 021620 describes MUCINEX DM, which is a drug marketed by Reckitt Benckiser and is included in one NDA. It is available from six suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the MUCINEX DM profile page.

The generic ingredient in MUCINEX DM is dextromethorphan hydrobromide; guaifenesin. There are twenty-two drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; guaifenesin profile page.

Summary for NDA: 021620

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021620

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MUCINEX DM
dextromethorphan hydrobromide; guaifenesin
 TABLET, EXTENDED RELEASE;ORAL 021620 NDA ATLANTIC BIOLOGICALS CORP 17856-0056 17856-0056-1 1 TABLET, EXTENDED RELEASE in 1 PACKAGE (17856-0056-1)
MUCINEX DM
dextromethorphan hydrobromide; guaifenesin
 TABLET, EXTENDED RELEASE;ORAL 021620 NDA Physicians Total Care, Inc. 54868-5853 54868-5853-0 2 BLISTER PACK in 1 CARTON (54868-5853-0) > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET, EXTENDED RELEASE;ORALStrength60MG;1.2GM
Approval Date:Apr 29, 2004TE:RLD:Yes
Patent:6,372,252Patent Expiration:Apr 28, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:7,838,032Patent Expiration:Apr 28, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:6,955,821Patent Expiration:Apr 28, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:EXPECTORANT AND COUGH SUPPRESSANT


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Dow
Novartis
Fish and Richardson
Queensland Health
McKesson
US Army
Citi
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot